Newron Pharmaceuticals S.p.A. carries a market capitalization of 416.12M, placing it among publicly traded companies globally.
| Market Cap | 416.12M |
| Enterprise Value | N/A |
Newron Pharmaceuticals S.p.A.'s stock has gained approximately 0% over the past 52 weeks. The 50-day moving average sits at 20.00, while the 200-day moving average is 13.46.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0% |
| 50-Day Moving Average | 20.00 |
| 200-Day Moving Average | 13.46 |
| Average Volume (20 Days) | N/A |